-- Randomized controlled trial will add to results from prior open-label trial and in-practice case series -- DUBLIN--(BUSINESS WIRE)-- Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results